A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00044135
Recruitment Status : Unknown
Verified November 2002 by Triangle Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : August 21, 2002
Last Update Posted : June 24, 2005
Information provided by:
Triangle Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given